Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited West Africa (vol 48, pg 476, 2009)

G. S. Gottlieb; N. M. D. Badiane; S. E. Hawes; L. Fortes; M. Toure; C. T. Ndour; A. K. Starling; F. Traore; F. Sall; K. G. Wong; S. L. Cherne; D. J. Anderson; S. A. Dye; R. A. Smith; J. Mullins; N. B. Kiviat; P. S. Sow

doi:10.1086/597577

Retour

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited West Africa (vol 48, pg 476, 2009)

Article de revue

Avec comité de lecture

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited West Africa (vol 48, pg 476, 2009)

G. S. Gottlieb, N. M. D. Badiane, S. E. Hawes, L. Fortes, M. Toure, C. T. Ndour, A. K. Starling, F. Traore, F. Sall, K. G. Wong, …

Clinical infectious diseases, Vol.48(6), pp.848-848

15/03/2009

DOI: https://doi.org/10.1086/597577

Résumé

Immunology

Infectious Diseases

Life Sciences & Biomedicine

Microbiology

Science & Technology

Indicateurs

1 Consultations de la notice

Détails

Titre: Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resource-limited West Africa (vol 48, pg 476, 2009)
Créateurs - sans rôle: G. S. Gottlieb - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
N. M. D. Badiane - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
S. E. Hawes - University of Washington
L. Fortes - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
M. Toure - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
C. T. Ndour - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
A. K. Starling - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
F. Traore - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
F. Sall - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
K. G. Wong - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
S. L. Cherne - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
D. J. Anderson - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
S. A. Dye - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
R. A. Smith - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
J. Mullins - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
N. B. Kiviat - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
P. S. Sow - Univ Washington, Dakar HIV Study Group 2, Seattle, WA 98195 USA
Détails de publication: Clinical infectious diseases, Vol.48(6), pp.848-848
Éditeur: Oxford Univ Press
Nombre de pages: 1
Identifiants: 99158562609311
Unité académique: Recherches translationnelles sur le VIH et les Maladies Infect. Endém. émerg. - TransVIHMI
Langue: English
Type de ressource: Journal article